ZhangB, WuW, ShangX, et al.Incidence and prognosis of thyroid cancer in children: Based on the SEER database. Pediatr Surg Int2022;38:445‐456; doi: 10.1007/s00383-022-05069-3.
2.
LimH, DevesaSS, SosaJA, et al.Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA2017;317:1338‐1348; doi: 10.1001/jama.2017.2719.
3.
HayID, Gonzalez-LosadaT, ReinaldaMS, et al.Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg2010;34:1192‐1202; doi: 10.1007/s00268-009-0364-0.
4.
GolpanianS, PerezEA, TashiroJ, et al.Pediatric papillary thyroid carcinoma: Outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int2016;32:201‐208; doi: 10.1007/s00383-015-3855-0.
5.
Klein HesselinkMS, NiesM, BoccaG, et al.Pediatric differentiated thyroid carcinoma in The Netherlands: A nationwide follow-up study. J Clin Endocrinol Metab2016;101:2031‐2039; doi: 10.1210/jc.2015-3290.
6.
WadaN, SuginoK, MimuraT, et al.Treatment strategy of papillary thyroid carcinoma in children and adolescents: Clinical significance of the initial nodal manifestation. Ann Surg Oncol2009;16:3442‐3449; doi: 10.1245/s10434-009-0673-4.
7.
FrancisGL, WaguespackSG, BauerAJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid2015;25:716‐759; doi: 10.1089/thy.2014.0460.
8.
ValenciagaP, LiyanarachchiA, BrockPL, RingelMD. Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood. J Clin Endocrinol Metab, Epub2025:dgaf522; doi: 10.1210/clinem/dgaf522.
9.
RingelMD, SosaJA, BalochZ, et al.2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid2025;35(8):841‐985; doi: 10.1177/10507256251363120.
10.
PapaleontiouM, GenereN. Setting the tone—pretreatment understanding is associated with treatment-related expectations among thyroid cancer survivors. JAMA Otolaryngol Head Neck Surg2023;149:120‐121; doi: 10.1001/jamaoto.2022.4110.
11.
AnJJ, ChoiMS, YangC, et al.Age-specific risk of second primary malignant neoplasm after radioactive iodine treatment for differentiated thyroid cancer. JAMA Otolaryngol Head Neck Surg2025;151:947‐956; doi: 10.1001/jamaoto.2025.2626.
